Licenses are an effective manner in which to monetize a life science company’s intellectual property while retaining ownership and creating a revenue stream for the company. We have represented clients around the globe negotiating global license and regional licenses with terms that match the client’s needs and drive revenues into our clients’ business. These licenses include human and animal drugs, medical devices, and biologics, as well as other life science technologies. We have licensed the development and use of novel compounds, trademarks, trade secrets and, where appropriate, copyrights.
Our Life Science attorneys understand emerging technology companies have different business pressures and specific requirements that need to be negotiated in the license in light of limited internal resources. Further, those licenses need to reflect appropriate expertise and allocation of risk for emerging technology companies. Our attorneys are skilled in negotiating these licenses to achieve reasonable outcomes for our clients. We also represent larger life science companies wishing to divest themselves of assets the company no longer wishes to pursue. We have significant experience helping clients sell technologies that are not critical to their core mission or are better developed by others.